Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
46.13
-1.29 (-2.72%)
At close: Feb 21, 2025, 4:00 PM
46.50
+0.37 (0.80%)
After-hours: Feb 21, 2025, 5:42 PM EST
Soleno Therapeutics Market Cap
Soleno Therapeutics has a market cap or net worth of $1.99 billion as of February 21, 2025. Its market cap has increased by 43.27% in one year.
Market Cap
1.99B
Enterprise Value
1.71B
1-Year Change
43.27%
Ranking
Category
Stock Price
$46.13
Market Cap Chart
Since November 13, 2014, Soleno Therapeutics's market cap has increased from $24.70M to $1.99B, an increase of 7,952.66%. That is a compound annual growth rate of 53.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 1.99B | 2.63% |
| Dec 31, 2024 | 1.94B | 57.88% |
| Dec 29, 2023 | 1.23B | 7,477.78% |
| Dec 30, 2022 | 16.20M | -50.46% |
| Dec 31, 2021 | 32.70M | -78.72% |
| Dec 31, 2020 | 153.70M | 17.06% |
| Dec 31, 2019 | 131.30M | 257.77% |
| Dec 31, 2018 | 36.70M | 103.89% |
| Dec 29, 2017 | 18.00M | 40.63% |
| Dec 30, 2016 | 12.80M | -44.10% |
| Dec 31, 2015 | 22.90M | 126.73% |
| Dec 31, 2014 | 10.10M | -59.11% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |